Leap Therapeutics
LPTX
$1.80
Share price
-1.10%
Change (1 day)
-43.22%
Change (1 year)
Categories
Leap Therapeutics (LPTX) - Total liabilities
Total liabilities on the balance sheet as of March 2024 : $10.59 M
According to Leap Therapeutics 's latest financial reports the company's total liabilities are $10.59 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Leap Therapeutics - Total liabilities on balance sheet (from 2013 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $11.48 M | 14.59% |
| 2021-12-31 | $10.02 M | 29.84% |
| 2020-12-31 | $7.72 M | -16.06% |
| 2019-12-31 | $9.19 M | -7.09% |
| 2018-12-31 | $9.89 M | -44.84% |
| 2017-12-31 | $17.94 M | -83.18% |
| 2016-12-31 | $0.10 B | 49.11% |
| 2015-12-31 | $71.54 M | 2775.76% |
| 2014-12-31 | $2.48 M | 26.23% |
| 2013-12-31 | $1.97 M | -57.27% |
| 2012-12-31 | $4.61 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $22.14 M | 109.05% | 🇺🇸 USA |